- Quick guide to PET-CT imaging, allowing easy image interpretation and rapid review of key information
- Completely revised and updated edition in a user-friendly format
- Covers the integrative use of contrast-enhanced CT and MRI
- Includes non-oncological indications for FDG PET-CT
This new atlas, the fourth of a successful series, is a completely revised and updated edition of a previously published FDG PET-CT atlas. In the past few years, considerable progress has been made in the field of PET-CT imaging, and this new edition takes full account of these recent developments. Furthermore, its educational mission has been broadened: beyond serving as a straightforward guide to FDG PET-CT imaging it now encompasses the integrative use of contrast-enhanced CT and MRI. The new edition also includes non-oncological indications for FDG PET-CT.
The atlas aims to help imaging practitioners to recognize physiological and benign pathological FDG uptake and illustrates in a case-based, practical manner the PET-CT appearances of all the major tumors and infectious, inflammatory, and neurodegenerative disorders. The main clinical applications are covered, and learning points and pitfalls are clearly articulated.
The consistent, user-friendly format facilitates image interpretation and allows rapid review of key information needed for FDG PET-CT imaging.
Table of Contents- Premises to PET/CT with FDG in Oncology
- Normal Distribution, Variants, and Artifacts (Versus Pathological Uptake in Malignant and Benign Diseases)
- Malignancies in Hematology
- Malignancies in Dermatology
- Thoracic Malignancies
- Breast Cancer
- Head and Neck Malignancies
- Gynecological Malignancies
- Malignancies of the Upper Gastrointestinal Tract
- Malignancies of Lower Gastroenterological Tract
- Urological Malignancies
- Malignancy in Orthopedics
- Cancers of Unknown Origin
- Infection and Inflammation
- Brain 18F-Fluorodeoxyglucose (FDG) PET
